Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 189

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G 1 cyclins/cyclin‐dependent kinases and the phosphoinositide 3‐kinase/AKT signaling cascade

Open access
Wei, Tong‐You W., Juan, Chi‐Chang, Hisa, Jiun‐Yi, Su, Li‐Jen, Lee, Yuan‐Chii G., Chou, Hsiang‐Yun, Chen, Jo‐Mei M., Wu, Yu‐Chung, Chiu, Shao‐Chih, Hsu, Chung‐Ping, Liu, Kuo‐Lin, Yu, Chang‐Tze R. · 2012 · Cancer Science

Abstract

Increasing evidence suggests that PRMT 5, a protein arginine methyltransferase, is involved in tumorigenesis. However, no systematic research has demonstrated the cell‐transforming activity of PRMT 5. We investigated the involvement of PRMT 5 in tumor formation. First, we showed that PRMT 5 was associated with many human cancers, through statistical analysis of microarray data in the NCBI GEO database. Overexpression of ectopic PRMT 5 per se or its specific sh RNA enhanced or reduced cell growth under conditions of normal or low concentrations of serum, low cell density, and poor cell attachment. A stable clone that expressed exogenous PRMT 5 formed tumors in nude mice, which demonstrated that PRMT 5 is a potential oncoprotein.PRMT 5 accelerated cell cycle progression through G 1 phase and modulated regulators of G 1; for example, it upregulated cyclin‐dependent kinase (CDK) 4,CDK 6, and cyclins D 1,D 2 and E 1, and inactivated retinoblastoma protein (R b). Moreover,PRMT 5 activated phosphoinositide 3‐kinase (PI 3K)/AKT and suppressed c‐J un N‐terminal kinase (JNK)/c‐J un signaling cascades. However, only inhibition of PI 3 K activity, and not overexpression of JNK, blocked PRMT 5‐induced cell proliferation. Further analysis of PRMT 5 expression in 64 samples of human lung cancer tissues by microarray and western blot analysis revealed a tight association of PRMT 5 with lung cancer. Knockdown of PRMT 5 retarded cell growth of lung cancer cell lines A 549 and H 1299. In conclusion, to the best of our knowledge, we have characterized the cell‐transforming activity of PRMT 5 and delineated its underlying mechanisms for the first time.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1349-7006.2012.02367.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 189

Metadata

Authors
Wei, T. W., Juan, C., Hisa, J., Su, L., Lee, Y. G., Chou, H., Chen, J. M., Wu, Y., Chiu, S., Hsu, C., Liu, K., & Yu, C. R.
Venue
Cancer Science
Publisher
Wiley
Published
2012-08-08
Volume
103
Issue
9
Pages
1640-1650
ISSN
  • 1347-9032 (ISSN-L)
  • 1349-7006
OpenAlex
W2036400107
Cited by
189
References
1
FWCI
3.25
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G 1 cyclins/cyclin‐dependent kinases and the phosphoinositide 3‐kinase/AKT signaling cascade. https://app.cochat.ai/papers/10.1111/j.1349-7006.2012.02367.x
The paper
Wei, T. W., Juan, C., Hisa, J., Su, L., Lee, Y. G., Chou, H., Chen, J. M., Wu, Y., Chiu, S., Hsu, C., Liu, K., & Yu, C. R. (2012). Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G 1 cyclins/cyclin‐dependent kinases and the phosphoinositide 3‐kinase/AKT signaling cascade. Cancer Science. https://doi.org/10.1111/j.1349-7006.2012.02367.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.